Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CGS 15855A

Known as: 2H-(1)Benzopyrano(3,4-b)pyridin-9-ol, 1,3,4,4a,5,10b-hexahydro-4-propyl-, trans-(+-)-, CGS-15855-A, CGS-15855A 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Qualitative differences in pharmacological responsiveness to various types of dopamine agonists have been reported in rats that… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
Highly Cited
1998
Highly Cited
1998
In the present study, a novel and exceptionally sensitive method of high-performance liquid chromatography coupled to coulometric… Expand
Highly Cited
1995
Highly Cited
1995
Using [125I]-iodosulpride as a radioligand, the novel naphthofurane, (+/-)-S 11566 [(+/-)-[7-(N,N-dipropylamino)-5,6,7,8-tetra… Expand
Highly Cited
1995
Highly Cited
1995
The preferential dopamine (DA) D3 versus D2 receptor agonist, (+)-7-OH-DPAT, dose-dependently decreased DA synthesis in the… Expand
1989
1989
The effects of apomorphine and the putative dopamine autoreceptor agonist, CGS 15855A, were evaluated in several functional… Expand
1988
1988
The metabolism and release of dopamine by rat mesostriatal and mesolimbic dopamine neurons were determined after 2 or 14 days of… Expand
1987
1987
The ability of dopamine autoreceptor agonists to suppress the in vivo release or metabolism of dopamine in mouse brain was… Expand
Highly Cited
1987
Highly Cited
1987
Abstract: The capacity of D1 and D2 agonists and antagonists to regulate the in vivo release and metabolism of dopamine (DA) in… Expand
1987
1987
The regulation by autoreceptors of dopamine release in the rat neocortex was inferred from measurements of 3-methoxytyramine… Expand